Chemoinformaics analysis of 14-HYDROXY-9-EPI-CARYOPHYLLENE
| Molecular Weight | 220.356 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -4.088 | nHRing | 0 |
| Solubility: LogP | 4.138 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.668 |
| Synth | 4.299 |
| Natural Product Likeliness | 3.258 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.107 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.463 |
| MDCK | 0.0000131 |
| BBB | 0.956 |
| PPB | 0.872715 |
| VDSS | 1.876 |
| FU | 0.123914 |
| CYP1A2-inh | 0.207 |
| CYP1A2-sub | 0.215 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.52 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.72 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.821 |
| CYP3a4-inh | 0.067 |
| CYP3a4-sub | 0.239 |
| CL | 9.093 |
| T12 | 0.162 |
| hERG | 0.017 |
| Ames | 0.017 |
| ROA | 0.039 |
| SkinSen | 0.334 |
| Carcinogencity | 0.625 |
| EI | 0.68 |
| Respiratory | 0.451 |
| NR-Aromatase | 0.033 |
| Antiviral | Yes |
| Prediction | 0.865164 |